RA
CFMS

Royce & Associates’s Conformis, Inc. Common Stock CFMS Stock Holding History

Royce & Associates’s Portfolio CFMS Stock Details CFMS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-1,992
Closed -$75K – 1205
2019
Q4 		$75K Buy
1,992
+400
+25% +$19K ﹤0.01% 1007
2019
Q3 		$74K Buy
1,592
+835
+110% +$50.2K ﹤0.01% 1014
2019
Q2 		$82K Buy
+757
New +$62.3K ﹤0.01% 1018
2016
Q4 		– Sell
-9,224
Closed -$2.29M – 1115
2016
Q3 		$2.29M Hold
9,224
– – 0.02% 763
2016
Q2 		$1.62M Buy
9,224
+2,000
+28% +$470K 0.01% 850
2016
Q1 		$1.94M Buy
7,224
+4,320
+149% +$1.14M 0.01% 832
2015
Q4 		$1.25M Hold
2,904
– – 0.01% 908
2015
Q3 		$1.31M Buy
+2,904
New +$1.46M 0.01% 936

Other funds holding CFMS

Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $246M AUM 130.69% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Royce & Associates's CFMS Position: Q1 2020 in Review

Royce & Associates sold out of Conformis, Inc. Common Stock (CFMS) in Q1 2020, closing a stake of 1,992 shares — an estimated $75K sold.

Royce & Associates first reported a position in CFMS in Q3 2015 and held it in 8 quarters. The position peaked at $2.29M in Q3 2016. 73 funds tracked by Wall St. Rank hold CFMS as of Q1 2020.

  • Royce & Associates reported no remaining Conformis, Inc. Common Stock position as of Q1 2020 after selling out during the quarter.
  • Royce & Associates sold 1,992 Conformis, Inc. Common Stock shares in Q1 2020, an estimated $75K.
  • Royce & Associates first reported a position in Conformis, Inc. Common Stock in Q3 2015 and held it in 8 quarters.
  • Royce & Associates's Conformis, Inc. Common Stock position peaked at $2.29M in Q3 2016.
  • 73 funds tracked by Wall St. Rank held Conformis, Inc. Common Stock as of Q1 2020.

Based on Royce & Associates's 13F filing for Q1 2020, filed 12 May 2020.